insights_auto
Why is CSL down 2.41%?
Dive Deeperchevron_right
CSL:ASX
CSL Ltd
A$191.95
arrow_downward
-2.41%(-4.75) 1D
Oct 26, 12:11:22 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSL...
Open
A$194.00
High
A$195.97
Low
A$191.55
Mkt. cap
92.11B
Avg. vol.
1.15M
Volume
261.84K
Dividend
1.48%
Quarterly dividend
A$0.71
Ex-dividend date
Sep 9, 2026
52-wk high
A$213.85
52-wk low
A$90.00
EPS
-A$7.62
Shares outstanding
479.88M
No. of employees
29K
Open
A$194.00
High
A$195.97
Low
A$191.55
Mkt. cap
92.11B
Avg. vol.
1.15M
Volume
261.84K
Dividend
1.48%
Quarterly dividend
A$0.71
Ex-dividend date
Sep 9, 2026
52-wk high
A$213.85
52-wk low
A$90.00
EPS
-A$7.62
Shares outstanding
479.88M
No. of employees
29K
News stories
From web sources and news partners
The Motley Fool Australia
·
55 minutes ago
Would I buy and hold CSL and Cochlear shares for 10 years?
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL Ltd
CEOPaul McKenzie
Employees29K
Founded1916
HeadquartersMelbourne, Victoria, Australia
SectorBiotechnology
Websitecsl.com